Cargando…
Topical co‐administration of zoledronate with recombinant human bone morphogenetic protein-2 can induce and maintain bone formation in the bone marrow environment
BACKGROUND: Bone morphogenetic proteins (BMPs) induce osteogenesis in various environments. However, when BMPs are used alone in the bone marrow environment, the maintenance of new bone formation is difficult owing to vigorous bone resorption. This is because BMPs stimulate the differentiation of no...
Autores principales: | Ueyama, Hideki, Ohta, Yoichi, Imai, Yuuki, Suzuki, Akinobu, Sugama, Ryo, Minoda, Yukihide, Takaoka, Kunio, Nakamura, Hiroaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819170/ https://www.ncbi.nlm.nih.gov/pubmed/33472600 http://dx.doi.org/10.1186/s12891-021-03971-w |
Ejemplares similares
-
Bone Morphogenetic Protein 2 Promotes Bone Formation in Bone Defects in Which Bone Remodeling Is Suppressed by Long-Term and High-Dose Zoledronic Acid
por: Moon, Young Jae, et al.
Publicado: (2023) -
Bone Morphogenetic Protein Receptor in the Osteogenic Differentiation of Rat Bone Marrow Stromal Cells
por: Wang, Anxun, et al.
Publicado: (2010) -
Differences in the setting of acetabular component alignment guides between the supine and lateral positions for total hip arthroplasty
por: Minoda, Yukihide, et al.
Publicado: (2021) -
Regulation of Bone Morphogenetic Protein Signaling by ADP-ribosylation
por: Watanabe, Yukihide, et al.
Publicado: (2016) -
Overexpression of Bone Morphogenetic Protein-1 Promotes Osteogenesis of Bone Marrow Mesenchymal Stem Cells In Vitro
por: Su, Zhongping, et al.
Publicado: (2020)